1. Home
  2. CABO vs IMCR Comparison

CABO vs IMCR Comparison

Compare CABO & IMCR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cable One Inc.

CABO

Cable One Inc.

HOLD

Current Price

$133.64

Market Cap

603.1M

ML Signal

HOLD

Logo Immunocore Holdings plc

IMCR

Immunocore Holdings plc

HOLD

Current Price

$36.52

Market Cap

1.7B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CABO
IMCR
Founded
1980
2008
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Cable & Other Pay Television Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Telecommunications
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
603.1M
1.7B
IPO Year
N/A
2021

Fundamental Metrics

Financial Performance
Metric
CABO
IMCR
Price
$133.64
$36.52
Analyst Decision
Hold
Buy
Analyst Count
3
9
Target Price
$126.00
$67.00
AVG Volume (30 Days)
147.0K
338.1K
Earning Date
11-06-2025
11-06-2025
Dividend Yield
2.23%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$1,524,897,000.00
$379,590,000.00
Revenue This Year
N/A
$32.31
Revenue Next Year
N/A
$10.50
P/E Ratio
N/A
N/A
Revenue Growth
N/A
28.11
52 Week Low
$96.67
$23.15
52 Week High
$390.25
$40.72

Technical Indicators

Market Signals
Indicator
CABO
IMCR
Relative Strength Index (RSI) 57.32 49.05
Support Level $119.44 $35.35
Resistance Level $128.95 $40.71
Average True Range (ATR) 6.61 1.82
MACD 3.79 -0.45
Stochastic Oscillator 87.37 22.55

Price Performance

Historical Comparison
CABO
IMCR

About CABO Cable One Inc.

Cable One Inc. is a telecommunications company that generates revenue from providing broadband, voice, and video services to both residential and business customers. From a product standpoint, the majority of revenue comes from data and video services, which are subscription-based and billed monthly. The company also offers Sparklight TV, an Internet Protocol Television (IPTV) service that enables customers using the Sparklight TV app to stream video channels from the cloud. Additionally, the company earns advertising revenue by selling airtime on its video channels, and it provides voice services over Internet protocols. Cable One Inc. owns its telecommunications infrastructure.

About IMCR Immunocore Holdings plc

Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.

Share on Social Networks: